DOW INC. 8-K

What Happened
Dow Inc. announced on January 29, 2026 (press release) a company-wide program called "Transform to Outperform" to simplify operations, reset its cost structure and accelerate growth. The Board approved, on January 26, 2026, severance and related benefit costs for a global workforce reduction of approximately 4,500 roles. Dow is targeting at least $2 billion of near-term Operating EBITDA (Op. EBITDA) improvement and expects to record related charges in 2026 and 2027.

Key Details

• Plan target: at least $2.0 billion in near-term Op. EBITDA uplift (about two-thirds productivity, one-third growth).
• Workforce reduction: ~4,500 roles globally; severance and related benefit costs expected to be $600 million to $800 million.
• Total one-time costs for the program: estimated $1.1 billion to $1.5 billion (includes $600–800M severance + $500–700M other one-time costs).
• Cash timing: costs and cash outlays for the workforce reduction expected to be $70 million to $90 million; overall cash costs primarily over the next two years.
• Year-by-year projection (company-provided): 2026 = $500M Op. EBITDA uplift (cash cost $800–1,000M in-year); 2027 = $1,200M incremental uplift (cash cost $300–500M in-year); 2028 = $300M incremental uplift (no cash cost).
• Governance & compliance: Dow said it will engage local stakeholders and follow applicable local consultation processes. Company context: ~34,600 employees and ~$40B sales in 2025.

Why It Matters
For investors, the plan signals a major restructuring intended to boost near-term operating profitability (Op. EBITDA) by $2B, but it will also produce material one-time charges and near-term cash costs recorded in 2026–2027. The estimated $1.1–1.5B of one-time charges (including $600–800M in severance) and related cash outlays will affect near-term reported results, while the company expects the actions to be accretive to prior earnings levels over time. Tracking the timing and magnitude of the charges, realized cost savings, and execution progress will be important to assess whether the program delivers the targeted improvement in margins and shareholder returns.